Understanding Biofilm-Phage Interactions in Cystic Fibrosis Patients Using Mathematical Frameworks

arXiv2306.01791MaRDI QIDQ6439056

Claire Canner, Doris Hartung, Ephraim Agyingi, Maya Williams, Ricardo N. G Reyes Grimaldo, Robert Osgood, Blessing O. Emerenini

Publication date: 31 May 2023

Abstract: When planktonic bacteria adhere together to a surface, they begin to form biofilms, or communities of bacteria. Biofilm formation in a host can be extremely problematic if left untreated, especially since antibiotics can be ineffective in treating the bacteria. Certain lung diseases such as cystic fibrosis can cause the formation of biofilms in the lungs and can be fatal. With antibiotic-resistant bacteria, the use of phage therapy has been introduced as an alternative or an additive to the use of antibiotics in order to combat biofilm growth. Phage therapy utilizes phages, or viruses that attack bacteria, in order to penetrate and eradicate biofilms. In order to evaluate the effectiveness of phage therapy against biofilm bacteria, we adapt an ordinary differential equation model to describe the dynamics of phage-biofilm combat in the lungs. We then create our own phage-biofilm model with ordinary differential equations and stochastic modeling. Then, simulations of parameter alterations in both models are investigated to assess how they will affect the efficiency of phage therapy against bacteria. By increasing the phage mortality rate, the biofilm growth can be balanced and allow the biofilm to be more vulnerable to antibiotics. Thus, phage therapy is an effective aid in biofilm treatment.

This page was built for publication: Understanding Biofilm-Phage Interactions in Cystic Fibrosis Patients Using Mathematical Frameworks

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6439056)